editore: Taylor & Francis Ltd
This is an authoritative clinical text on the use of oral terbinafine (Lamisil) as first-line therapy for onychomycosis (fungal nail infections) and as a rational choice for fungal skin infections that require oral therapy. Author Doctor R.J. Hay, reviews the data on Lamisil, presenting much of it in the form of especially helpful tables. Individual chapters cover pharmacology and pharmacokinetics and the use of Lamisil tablets in onychomycosis, tinea capitis, dermatomycoses, subcutaneous and systemic mycoses and other infectious diseases. Dr. Hay also provides a chapter on the safety and tolerability of Lamisil tablets, including the postmarketing surveillance study and interactions with other drugs.